209 related articles for article (PubMed ID: 35205311)
1. CRL4
Mazian MA; Yamanishi K; Rahman MZA; Ganasen M; Nishitani H
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205311
[TBL] [Abstract][Full Text] [Related]
2. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.
Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG
J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1.
Leng F; Saxena L; Hoang N; Zhang C; Lee L; Li W; Gong X; Lu F; Sun H; Zhang H
J Biol Chem; 2018 Dec; 293(49):18879-18889. PubMed ID: 30301766
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA Replication Licensing and Re-Replication by Cdt1.
Zhang H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068957
[TBL] [Abstract][Full Text] [Related]
5. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
[TBL] [Abstract][Full Text] [Related]
6. Docking of a specialized PIP Box onto chromatin-bound PCNA creates a degron for the ubiquitin ligase CRL4Cdt2.
Havens CG; Walter JC
Mol Cell; 2009 Jul; 35(1):93-104. PubMed ID: 19595719
[TBL] [Abstract][Full Text] [Related]
7. Direct role for proliferating cell nuclear antigen in substrate recognition by the E3 ubiquitin ligase CRL4Cdt2.
Havens CG; Shobnam N; Guarino E; Centore RC; Zou L; Kearsey SE; Walter JC
J Biol Chem; 2012 Mar; 287(14):11410-21. PubMed ID: 22303007
[TBL] [Abstract][Full Text] [Related]
8. PCNA-dependent ubiquitination of Cdt1 and p21 in mammalian cells.
Hayashi A; Suenaga N; Shiomi Y; Nishitani H
Methods Mol Biol; 2014; 1170():367-82. PubMed ID: 24906324
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T
EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of Cdt2 to PCNA is important for targeting the CRL4
Hayashi A; Giakoumakis NN; Heidebrecht T; Ishii T; Panagopoulos A; Caillat C; Takahara M; Hibbert RG; Suenaga N; Stadnik-Spiewak M; Takahashi T; Shiomi Y; Taraviras S; von Castelmur E; Lygerou Z; Perrakis A; Nishitani H
Life Sci Alliance; 2018 Dec; 1(6):e201800238. PubMed ID: 30623174
[TBL] [Abstract][Full Text] [Related]
11. Mutations at multiple CDK phosphorylation consensus sites on Cdt2 increase the affinity of CRL4
Nukina K; Hayashi A; Shiomi Y; Sugasawa K; Ohtsubo M; Nishitani H
Genes Cells; 2018 Mar; 23(3):200-213. PubMed ID: 29424068
[TBL] [Abstract][Full Text] [Related]
12. The CRL4Cdt2 ubiquitin ligase mediates the proteolysis of cyclin-dependent kinase inhibitor Xic1 through a direct association with PCNA.
Kim DH; Budhavarapu VN; Herrera CR; Nam HW; Kim YS; Yew PR
Mol Cell Biol; 2010 Sep; 30(17):4120-33. PubMed ID: 20606006
[TBL] [Abstract][Full Text] [Related]
13. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase.
Shibata E; Dar A; Dutta A
J Biol Chem; 2014 Aug; 289(33):23056-23064. PubMed ID: 24962565
[TBL] [Abstract][Full Text] [Related]
14. Thymine DNA glycosylase is a CRL4Cdt2 substrate.
Slenn TJ; Morris B; Havens CG; Freeman RM; Takahashi TS; Walter JC
J Biol Chem; 2014 Aug; 289(33):23043-23055. PubMed ID: 24947512
[TBL] [Abstract][Full Text] [Related]
15. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex.
Abbas T; Sivaprasad U; Terai K; Amador V; Pagano M; Dutta A
Genes Dev; 2008 Sep; 22(18):2496-506. PubMed ID: 18794347
[TBL] [Abstract][Full Text] [Related]
16. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.
Kim Y; Starostina NG; Kipreos ET
Genes Dev; 2008 Sep; 22(18):2507-19. PubMed ID: 18794348
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.
Havens CG; Walter JC
Genes Dev; 2011 Aug; 25(15):1568-82. PubMed ID: 21828267
[TBL] [Abstract][Full Text] [Related]
18. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.
Abbas T; Keaton M; Dutta A
Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434
[TBL] [Abstract][Full Text] [Related]
19. A DNA-binding domain in the C-terminal region of Cdt2 enhances the DNA synthesis-coupled CRL4Cdt2 ubiquitin ligase activity for Cdt1.
Mazian MA; Suenaga N; Ishii T; Hayashi A; Shiomi Y; Nishitani H
J Biochem; 2019 Jun; 165(6):505-516. PubMed ID: 30649446
[TBL] [Abstract][Full Text] [Related]
20. PIP degron proteins, substrates of CRL4Cdt2, and not PIP boxes, interfere with DNA polymerase η and κ focus formation on UV damage.
Tsanov N; Kermi C; Coulombe P; Van der Laan S; Hodroj D; Maiorano D
Nucleic Acids Res; 2014 Apr; 42(6):3692-706. PubMed ID: 24423875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
